Category: News

The moment an employee discovers systemic wrongdoing within their organization—whether it be financial fraud, safety violations, or environmental hazards—a ticking clock begins. This clock doesn’t just measure the time until the truth comes out; it measures the narrow window in which the employee must protect their career, their finances, and their legal standing. When a...

The case of United States et al. ex rel. Schutte et al. v. SuperValu Inc. et al, 598 U.S. 739 (2023), is not just a story of pharmacy overcharging; it is the most significant Supreme Court ruling on the False Claims Act (FCA) in a generation. The Core Dispute: What is “Usual and Customary”? The...

In the complex machinery of the American healthcare system, trust is the primary lubricant. We trust that when a doctor writes a prescription, it is necessary. We trust that when a pharmacy bills the government, it has actually provided a service. However, a landmark whistleblower case settled in late 2024 (and finalized for public record...

On January 29, 2026, the Department of Justice (DOJ) Antitrust Division did something it has never done in its decades-long history: it cut a check for $1 million to an individual whistleblower. This payment wasn’t just a reward for “doing the right thing.” It was the culmination of a high-stakes investigation into EBLOCK Corporation, an...

When the CARES Act was passed in early 2020, its primary vehicle for business support was the Paycheck Protection Program (PPP). Designed to keep employees on payroll, the program relied on “self-certification” of eligibility—a feature that saved millions of jobs but also invited unprecedented levels of fraud. As of January 16, 2026, the Department of...

Recent court rulings are changing the rules for healthcare whistleblowers, particularly in cases involving “kickbacks”. If you’ve witnessed a system designed to “nudge” doctors toward certain expensive drugs or services, a major new legal decision from 2025—United States v. Regeneron Pharmaceuticals—may impact how those cases are handled. What Happened in the Regeneron Case? The government...

For decades, the False Claims Act (FCA) has been one of the government’s most potent weapons against fraud, driven largely by “qui tam” provisions that allow private whistleblowers (relators) to sue on the government’s behalf. However, a series of recent legal challenges as to the constitutionality of  “qui tam” actions has brought these provisions into question. With the...

The fiscal year 2024 marked a groundbreaking period in the enforcement of the False Claims Act (FCA), with settlements and judgments exceeding $2.9 billion. This milestone highlights the effectiveness of whistleblower efforts and government initiatives in combating fraud and preserving taxpayer dollars. Principal Deputy Associate Attorney General Benjamin C. Mizer and Principal Deputy Assistant Attorney...

In a notable False Claims Act resolution, R&K Enterprises Inc. (R&K), a company based in Newport News, Virginia, has agreed to pay more than $2.6 million to resolve allegations of misrepresenting its eligibility for small business set-aside contracts. This case pointed out opportunities to commit fraud within the programs set up to aid small businesses, showing...